Arkolith/Insider Trading/NKGN/Form 4

Graf James A

Interim CFONKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Dec 5, 2023
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 4, 2023Buy(P)450$3.19$1K693
Dec 1, 2023Buy(P)220$3.35$737243

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-057369) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML